What are Neurotoxin drugs?

Neurotoxin drugs are pharmacologic agents that share a common mechanism (typically targeting SNARE complex). 0 are currently marketed, with 4 more in clinical development.

Neurotoxin

0 marketed 2 in Phase 3 2 in Phase 2

This page covers all Neurotoxin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SNARE complex, SNARE complex (synaptobrevin/VAMP), Botulinum toxin type A.

Targets

SNARE complex · SNARE complex (synaptobrevin/VAMP) · Botulinum toxin type A · SNARE proteins

Phase 3 pipeline (2)

botulinum toxin Type A (24 U) · Allergan · Neurology
Botulinum toxin Type A works by blocking the release of acetylcholine, a neurotransmitter that causes muscle contraction.
Botulinum toxin type A infiltrations · Aránzazu Vázquez Doce · Neurology, Dermatology, Pain Management
Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis.

Phase 2 pipeline (2)

BOTOX® purified neurotoxin complex · Allergan · Neurology
Botulinum toxin type A inhibits acetylcholine release at the neuromuscular junction.
Incobotulinumtoxin A · Ulthera, Inc · Neurology
Incobotulinumtoxin A is a neurotoxin that blocks the release of acetylcholine at neuromuscular junctions, leading to temporary muscle paralysis.